This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Grifols Therapeutics Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Afshin Safavi: Innovator in Amyloid Disease Treatment
Introduction
Afshin Safavi is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medicine, particularly in the treatment of diseases related to amyloid deposition. His innovative approach has the potential to impact many lives.
Latest Patents
Afshin Safavi holds 1 patent for a method of treatment and prophylaxis of diseases associated with β-amyloid polypeptides. This invention involves the administration of an immunoglobulin preparation enriched in immunoglobulin M (IgM), along with pharmaceutical compositions that comprise such preparations. This method aims to treat or prevent diseases linked to amyloid deposition.
Career Highlights
Afshin Safavi is currently associated with Grifols Therapeutics Inc., where he continues to work on advancements in therapeutic methods. His expertise and dedication to research have positioned him as a valuable asset in the medical community.
Collaborations
He collaborates with esteemed colleagues, including Philip Scuderi, Jr. and Matthew G. Langevin. Their combined efforts contribute to the ongoing research and development in the field of amyloid-related diseases.
Conclusion
Afshin Safavi's work exemplifies the spirit of innovation in medical science. His contributions to the treatment of amyloid diseases highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile